OPPORTUNITY
The opportunity · what the numbers say it is worth
Our framework reads AVOID
Read at
$6,521.00
0.00 P/E · 0.00 fwd
Price history & projections · where it has been, where the models see it going
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
SCREEN
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
The common standard · AAOIFI
Used by most halal investing apps
✓ PASSES
Our stricter standard · asset-based
The one Titan applies
✓ PASSES
What these two standards are, and how they differ →
-
Business activity
Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
-
Debt load
Interest-bearing debt is just 0.0% of its assets, well under the one-third ceiling — it does not run on borrowed money.
Pass
-
Interest-bearing cash
Cash held in interest-bearing accounts and securities is 0.7% of assets, under the one-third limit.
Pass
-
Receivables
Money owed to the company is 15.5% of assets, under the 49% limit.
Pass
-
Revenue purity
Only 2.7% of revenue comes from non-compliant sources — under the 5% line.
Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
PLAIN
The business, in plain words · what the numbers mean
Why it gives us pause
On our numbers, the price already runs ahead of the business.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
JOURNAL
The dated journal · newest first, never edited
2026-08-05
Markup $6,521.00
+0.0% Entry 11
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (30 analysts) rates it none, with a mean price target of $6877. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-04
Markup $6,521.00
+0.0% Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (30 analysts) rates it none, with a mean price target of $6877. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-03
Markup $6,521.00
+0.0% Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (30 analysts) rates it none, with a mean price target of $6877. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-02
Markup $6,521.00
+0.0% Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (30 analysts) rates it none, with a mean price target of $6877. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-01
Markup $6,521.00
+0.0% Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (30 analysts) rates it none, with a mean price target of $6877. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-31
Markup $6,521.00
+0.0% Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (30 analysts) rates it none, with a mean price target of $6877. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-30
Markup $6,521.00
+0.0% Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (30 analysts) rates it none, with a mean price target of $6877. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-26
Markup · changed $6,521.00
+0.0% Entry 4
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (30 analysts) rates it none, with a mean price target of $6877.
2026-07-18
Accumulation $6,521.00
+0.0% Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (30 analysts) rates it none, with a mean price target of $6877.
2026-07-03
Accumulation $6,521.00
+0.0% Entry 2
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.